Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Gains from Investment Securities: 2016-2024

Historic Gains from Investment Securities for Whitehawk Therapeutics (WHWK) over the last 9 years, with Dec 2024 value amounting to -$518,000.

  • Whitehawk Therapeutics' Gains from Investment Securities was N/A to $7.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $7.6 million, marking a year-over-year change of. This contributed to the annual value of -$518,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Per Whitehawk Therapeutics' latest filing, its Gains from Investment Securities stood at -$518,000 for FY2024, which was down 0.00% from -$518,000 recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Gains from Investment Securities registered a high of $1.7 million during FY2021, and its lowest value of -$518,000 during FY2023.
  • In the last 3 years, Whitehawk Therapeutics' Gains from Investment Securities had a median value of -$518,000 in 2024 and averaged $68,333.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 347.60% in 2021, then tumbled by 141.74% in 2023.
  • Yearly analysis of 5 years shows Whitehawk Therapeutics' Gains from Investment Securities stood at $390,949 in 2020, then surged by 347.60% to $1.7 million in 2021, then decreased by 29.08% to $1.2 million in 2022, then crashed by 141.74% to -$518,000 in 2023, then remained steady at -$518,000 in 2024.